January 2020 Issue Table Of Contents
Source: Life Science Leader

From The Editor
Feature Articles
- The 5-Step Strategy That Saved Genmab From A Dire Outlook
- J&J And Merck Detail How They Are Investing For Impact
Capitol Perspectives
From Principles and Policy to Execution
Companies To Watch
Patient Perspectives
Industry Research
Inside The Industry
- Women On Boards: How We Get From Here To There
- How We Landed In The International Space Station
- Using Competitive Intelligence To Reduce Competitive Risks
- IP Due Diligence Checklist: What To Address Before Executing A Transaction
- A Small Biopharma That Doesn’t Use CROs
- How Biopharma Leaders Can Ward Off A Perfect Storm: Part 2
- How A Real Estate Strategy Can Fuel A Biopharma’s Growth
- How To Overcome The Challenge Of Valuing A Biotech
Leadership Lessons
Ask The Board
- When You Have Investors/VCs On Your Board, How Do You Help Them Keep Their Director Hat On Vs. Their Investor Hat When Making Decisions?
- The Overall Complexity Of Biopharma Operations Is Increasing. How Do You Strategize To Meet Current And Future Needs In The Most Efficient (e.g., Cost) Manner Possible?
- Have You Had To Retire Or Remove A Director From Your Board? If So, How Did You Approach It?
This website uses cookies to ensure you get the best experience on our website. Learn more